Tandem Diabetes (TNDM) Misses Q2 EPS by 21c, Revenues Beat; Offers FY20 Revenue Guidance Above Consensus, 3Q Revenues Outlook Below Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/15/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. SNDK
6. HTFL
7. ADYEN:NA
8. DVLT
9. ADYYF
10. WDAY

Go back to Tandem Diabetes (TNDM) Misses Q2 EPS by 21c, Revenues Beat; Offers FY20 Revenue Guidance Above Consensus, 3Q Revenues Outlook Below Consensus
TANDEM DIABETES (NASDAQ: TNDM) Delayed: 22.72 -0.41 (1.77%)
Previous Close $23.13    52 Week High $12.48 
Open $22.92    52 Week Low $1.60 
Day High $22.92    P/E N/A 
Day Low $22.36    EPS $-6.33 
Volume 1,686,886